Total Payments
$77,027
2024 Payments
$958.05
Companies
25
Transactions
196
Medicare Patients
6,964
Medicare Billing
$4.0M
Payment Breakdown by Category
Other$57,275 (74.4%)
Food & Beverage$8,483 (11.0%)
Travel$5,669 (7.4%)
Consulting$5,600 (7.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $54,675 | 20 | 71.0% |
| Food and Beverage | $8,483 | 151 | 11.0% |
| Travel and Lodging | $5,669 | 23 | 7.4% |
| Consulting Fee | $5,600 | 1 | 7.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2,600 | 1 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $67,607 | 78 | $0 (2023) |
| Carl Zeiss Meditec, Inc. | $3,030 | 6 | $0 (2020) |
| Genentech, Inc. | $1,559 | 15 | $0 (2024) |
| Allergan, Inc. | $881.65 | 15 | $0 (2021) |
| Alcon Vision LLC | $522.30 | 5 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $377.49 | 11 | $0 (2019) |
| Apellis Pharmaceuticals, Inc. | $360.25 | 3 | $0 (2023) |
| EyePoint Pharmaceuticals US, Inc. | $304.51 | 8 | $0 (2023) |
| Alcon Laboratories Inc | $296.23 | 3 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $280.33 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $958.05 | 13 | Genentech, Inc. ($400.79) |
| 2023 | $6,395 | 16 | ABBVIE INC. ($5,615) |
| 2022 | $1,759 | 22 | ABBVIE INC. ($1,119) |
| 2021 | $224.25 | 6 | Genentech, Inc. ($138.89) |
| 2020 | $2,805 | 6 | Carl Zeiss Meditec, Inc. ($2,649) |
| 2019 | $19,236 | 48 | AbbVie, Inc. ($17,968) |
| 2018 | $30,775 | 58 | AbbVie, Inc. ($29,063) |
| 2017 | $14,874 | 27 | AbbVie, Inc. ($13,841) |
All Payment Transactions
196 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | Topcon Healthcare, Inc. | — | Food and Beverage | Cash or cash equivalent | $103.96 | General |
| 10/18/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $147.98 | General |
| Category: Ophthalmology | ||||||
| 10/02/2024 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $221.42 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/05/2024 | Topcon Healthcare, Inc. | — | Food and Beverage | Cash or cash equivalent | $45.90 | General |
| 06/28/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Ophthalmology | ||||||
| 06/13/2024 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $179.37 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/24/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 05/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $124.64 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/14/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/06/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Ophthalmology | ||||||
| 01/30/2024 | Coherus Biosciences Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Ophthalmology | ||||||
| 12/13/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: EYE CARE | ||||||
| 12/02/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $32.89 | General |
| 10/26/2023 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $149.13 | General |
| Category: Ophthalmology | ||||||
| 10/20/2023 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $15.85 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/16/2023 | Bausch & Lomb Americas Inc. | XIPERE (Drug), VISUDYNE | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Ophthalmology | ||||||
| 09/05/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $30.13 | General |
| 08/25/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/23/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $121.95 | General |
| Category: Ophthalmology | ||||||
| 06/08/2023 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $85.47 | General |
| Category: Ophthalmology | ||||||
| 05/30/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $116.50 | General |
| Category: TEPEZZA | ||||||
| 05/20/2023 | Genentech USA, Inc. | Susvimo (Drug), Vabysmo | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/03/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $113.83 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,933 | 10,985 | $4.1M | $1.4M |
| 2022 | 14 | 1,654 | 4,603 | $2.7M | $976,818 |
| 2021 | 17 | 1,647 | 4,726 | $2.3M | $860,066 |
| 2020 | 16 | 1,730 | 4,538 | $2.1M | $781,387 |
Total Patients
6,964
Total Services
24,852
Medicare Billing
$4.0M
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 154 | 1,344 | $2.5M | $927,115 | 36.5% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 17 | 5,460 | $390,554 | $158,565 | 40.6% |
| 67028 | Injection of drug into eye | Office | 2023 | 235 | 931 | $384,950 | $92,523 | 24.0% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 17 | 350 | $140,700 | $55,664 | 39.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 366 | 585 | $192,465 | $54,804 | 28.5% |
| 92134 | Imaging of retina | Office | 2023 | 548 | 1,524 | $160,020 | $47,938 | 30.0% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 83 | 232 | $68,120 | $17,005 | 25.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 119 | 119 | $50,932 | $14,738 | 28.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 110 | 110 | $42,790 | $12,230 | 28.6% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 13 | 13 | $37,648 | $12,068 | 32.1% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 70 | 76 | $25,156 | $8,646 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 52 | $17,108 | $4,741 | 27.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 37 | 47 | $10,951 | $3,070 | 28.0% |
| 92250 | Photography of the retina | Office | 2023 | 118 | 125 | $13,000 | $3,023 | 23.3% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 13 | 17 | $2,142 | $662.84 | 30.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 95 | 976 | $1.8M | $697,133 | 37.8% |
| 67028 | Injection of drug into eye | Office | 2022 | 172 | 776 | $253,740 | $75,608 | 29.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 329 | 501 | $145,716 | $45,678 | 31.3% |
| 92134 | Imaging of retina | Office | 2022 | 394 | 1,170 | $111,669 | $36,269 | 32.5% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2022 | 12 | 231 | $92,862 | $35,721 | 38.5% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 89 | 293 | $84,760 | $21,241 | 25.1% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2022 | 19 | 19 | $51,440 | $17,293 | 33.6% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 107 | 107 | $38,384 | $12,027 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 61 | 61 | $23,105 | $7,168 | 31.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 78 | 105 | $21,628 | $7,106 | 32.9% |
About Dr. Ashleigh Levison, MD
Dr. Ashleigh Levison, MD is a Ophthalmology healthcare provider based in Lafayette, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2009. The National Provider Identifier (NPI) number assigned to this provider is 1508093485.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashleigh Levison, MD has received a total of $77,027 in payments from pharmaceutical and medical device companies, with $958.05 received in 2024. These payments were reported across 196 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($54,675).
As a Medicare-enrolled provider, Levison has provided services to 6,964 Medicare beneficiaries, totaling 24,852 services with total Medicare billing of $4.0M. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Uveitis and Ocular Inflammatory Disease, Retina Specialist
- Location Lafayette, CO
- Active Since 06/17/2009
- Last Updated 03/11/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1508093485
Products in Payments
- Humira (Biological) $60,868
- OZURDEX (Drug) $7,616
- IOLMaster (Device) $2,600
- Lucentis (Biological) $1,061
- Vabysmo (Drug) $400.79
- YUTIQ (Drug) $271.48
- XIPERE (Drug) $271.37
- ReSTOR (Device) $270.39
- Syfovre (Drug) $235.78
- Clareon (Device) $234.60
- Non-Covered Product (Drug) $190.04
- SUSVIMO (Drug) $163.49
- ARTEVO 800 (Device) $159.01
- EYLEA HD (Biological) $154.09
- EYLEA (Biological) $126.24
- Constellation (Device) $121.12
- Cimerli (Biological) $117.30
- TEPEZZA (Drug) $116.50
- EYLEA AFLIBERCEPT INJECTION (Biological) $115.57
- ACTHAR (Biological) $111.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Lafayette
Shamik Bafna, Md, MD
Ophthalmology — Payments: $644,593
Ophthalmology $644,593
Robert Courtney, Md, MD
Ophthalmology — Payments: $10,231
Ophthalmology $10,231
Dr. Paul Azar, Md, MD
Ophthalmology — Payments: $10,081
Ophthalmology $10,081
Frederick Hall, Md, MD
Ophthalmology — Payments: $9,994
Ophthalmology $9,994
Dr. Julie Foreman, M.d, M.D
Ophthalmology — Payments: $9,286
Ophthalmology $9,286
Patrick Keating, Md, MD
Ophthalmology — Payments: $8,740
Ophthalmology $8,740